| Links | |
|---|---|
| etymological origin of | eng: dacetuzumab |
| etymological origin of | eng: daclizumab |
| etymological origin of | eng: dorlixizumab |
| etymological origin of | eng: eculizumab |
| etymological origin of | eng: efalizumab |
| etymological origin of | eng: epratuzumab |
| etymological origin of | eng: erlizumab |
| etymological origin of | eng: etaracizumab |
| etymological origin of | eng: felvizumab |
| etymological origin of | eng: fontolizumab |
| etymological origin of | eng: gemtuzumab ozogamicin |
| etymological origin of | eng: ibalizumab |
| etymological origin of | eng: inotuzumab ozogamicin |
| etymological origin of | eng: labetuzumab |
| etymological origin of | eng: lebrikizumab |
| etymological origin of | eng: lintuzumab |
| etymological origin of | eng: mepolizumab |
| etymological origin of | eng: milatuzumab |
| etymological origin of | eng: motavizumab |
| etymological origin of | eng: nimotuzumab |
| etymological origin of | eng: ocrelizumab |
| etymological origin of | eng: oportuzumab monatox |
| etymological origin of | eng: otelixizumab |
| etymological origin of | eng: palivizumab |
| etymological origin of | eng: pascolizumab |
| etymological origin of | eng: pertuzumab |
| etymological origin of | eng: pexelizumab |
| etymological origin of | eng: reslizumab |
| etymological origin of | eng: rontalizumab |
| etymological origin of | eng: rovelizumab |
| etymological origin of | eng: ruplizumab |
| etymological origin of | eng: sibrotuzumab |
| etymological origin of | eng: siplizumab |
| etymological origin of | eng: solanezumab |
| etymological origin of | eng: tadocizumab |
| etymological origin of | eng: talizumab |
| etymological origin of | eng: tanezumab |
| etymological origin of | eng: tefibazumab |
| etymological origin of | eng: teplizumab |
| etymological origin of | eng: tigatuzumab |
| etymological origin of | eng: toralizumab |
| etymologically related | eng: -mab |
| has derived form | eng: natalizumab |
| lexical category | affix |
Lexvo © 2008-2026 Gerard de Melo. Contact Legal Information / Imprint